Wenwu Dong

2.4k total citations
75 papers, 1.8k citations indexed

About

Wenwu Dong is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Wenwu Dong has authored 75 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Endocrinology, Diabetes and Metabolism, 26 papers in Surgery and 26 papers in Molecular Biology. Recurrent topics in Wenwu Dong's work include Thyroid Cancer Diagnosis and Treatment (41 papers), Thyroid and Parathyroid Surgery (23 papers) and Cancer-related molecular mechanisms research (16 papers). Wenwu Dong is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (41 papers), Thyroid and Parathyroid Surgery (23 papers) and Cancer-related molecular mechanisms research (16 papers). Wenwu Dong collaborates with scholars based in China, Japan and Germany. Wenwu Dong's co-authors include Hao Zhang, Zhihong Wang, Liang He, Wei Sun, Ping Zhang, Yuan Qin, Xiabin Lan, Ting Zhang, Ting Zhang and Weiping Teng and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Endocrinology.

In The Last Decade

Wenwu Dong

74 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenwu Dong China 24 852 779 657 451 167 75 1.8k
Minghua Ge China 23 653 0.8× 577 0.7× 347 0.5× 462 1.0× 423 2.5× 86 1.7k
Youben Fan China 22 560 0.7× 385 0.5× 399 0.6× 465 1.0× 293 1.8× 78 1.4k
Trisha Dwight Australia 23 514 0.6× 606 0.8× 588 0.9× 508 1.1× 356 2.1× 42 1.6k
Qinghai Ji China 24 339 0.4× 994 1.3× 215 0.3× 638 1.4× 262 1.6× 66 1.5k
Ning Qu China 22 358 0.4× 623 0.8× 209 0.3× 310 0.7× 283 1.7× 64 1.2k
Weiming Lv China 18 645 0.8× 313 0.4× 497 0.8× 180 0.4× 188 1.1× 44 1.2k
Tian Liao China 22 614 0.7× 349 0.4× 406 0.6× 131 0.3× 306 1.8× 71 1.4k
Shigeto Maeda Japan 18 536 0.6× 656 0.8× 183 0.3× 299 0.7× 535 3.2× 63 1.5k
Euy Young Soh South Korea 20 448 0.5× 1.2k 1.6× 171 0.3× 1.1k 2.4× 287 1.7× 60 2.0k
Agnese Biagini Italy 12 455 0.5× 1.1k 1.4× 144 0.2× 314 0.7× 365 2.2× 15 1.4k

Countries citing papers authored by Wenwu Dong

Since Specialization
Citations

This map shows the geographic impact of Wenwu Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenwu Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenwu Dong more than expected).

Fields of papers citing papers by Wenwu Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenwu Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenwu Dong. The network helps show where Wenwu Dong may publish in the future.

Co-authorship network of co-authors of Wenwu Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Wenwu Dong. A scholar is included among the top collaborators of Wenwu Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenwu Dong. Wenwu Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ziqi, et al.. (2024). Tumor differentiation-dependent conditional survival of patients with operable thyroid cancer. Frontiers in Endocrinology. 15. 1446312–1446312. 1 indexed citations
2.
Lv, Chengzhou, et al.. (2024). Relative burden of cancer and noncancer mortality among long-term survivors of differentiated thyroid cancer in the US. Frontiers in Endocrinology. 15. 1425634–1425634.
3.
Sun, Wei, Zhiyuan Wang, Yuan Qin, et al.. (2023). NEAT1_2/RRAD/EHF Positive Feedback Loop Facilitates Aerobic Glycolysis in Papillary Thyroid Cancer Cells. Endocrinology. 164(7). 7 indexed citations
4.
Ji, Xiaoyu, Chengzhou Lv, Jiapeng Huang, et al.. (2023). ALKBH5‐induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2. Cancer Science. 114(6). 2318–2334. 25 indexed citations
5.
Zheng, Yuenan, et al.. (2023). Dynamic estimates of survival in oncocytic cell carcinoma of the thyroid. Discover Oncology. 14(1). 217–217. 2 indexed citations
6.
Wang, Zhihong, Wei Sun, Liang He, et al.. (2022). Incidental T1 stage medullary thyroid carcinoma: The effect of tumour diameter on prognosis and therapeutic implications. Clinical Endocrinology. 97(3). 355–362. 4 indexed citations
7.
Dong, Wenwu, Kiyomi Horiuchi, Eiichiro Noguchi, & Takahiro Okamoto. (2022). Predictive value of metastatic lateral lymph node ratio for recurrence in pathologically lateral lymph node‐positive papillary thyroid cancer patients with palpable lymph nodes. Head & Neck. 44(7). 1623–1630. 2 indexed citations
8.
Huang, Jiapeng, Wei Sun, Zhihong Wang, et al.. (2022). FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. Journal of Experimental & Clinical Cancer Research. 41(1). 42–42. 141 indexed citations
9.
Qin, Yuan, Wei Sun, Zhihong Wang, et al.. (2021). A Meta-Analysis of Risk Factors for Transient and Permanent Hypocalcemia After Total Thyroidectomy. Frontiers in Oncology. 10. 614089–614089. 42 indexed citations
10.
Cai, Zhenyu, et al.. (2021). Microwave ablation of breast pseudoaneurysm. Pakistan Journal of Medical Sciences. 38(1). 323–325. 2 indexed citations
11.
He, Liang, Ting Zhang, Wei Sun, et al.. (2020). The DPP-IV inhibitor saxagliptin promotes the migration and invasion of papillary thyroid carcinoma cells via the NRF2/HO1 pathway. Medical Oncology. 37(11). 97–97. 13 indexed citations
12.
Zhang, Ping, Hao Zhang, Wenwu Dong, et al.. (2020). IL‐34 is a potential biomarker for the treatment of papillary thyroid cancer. Journal of Clinical Laboratory Analysis. 34(8). e23335–e23335. 7 indexed citations
13.
Shao, Liang, Wei Sun, Zhihong Wang, Wenwu Dong, & Yuan Qin. (2019). Long noncoding RNA SAMMSON promotes papillary thyroid carcinoma progression through p300/Sp1 axis and serves as a novel diagnostic and prognostic biomarker. IUBMB Life. 72(2). 237–246. 18 indexed citations
14.
Dong, Wenwu, et al.. (2019). Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up. Thyroid. 29(6). 802–808. 83 indexed citations
15.
Shao, Liang, Wei Sun, Hao Zhang, et al.. (2019). Risk factors for right paraesophageal lymph node metastasis in papillary thyroid carcinoma: A meta-analysis. Surgical Oncology. 32. 90–98. 12 indexed citations
16.
Qin, Yuan, Wei Sun, Hao Zhang, et al.. (2018). LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer. Endocrine. 59(3). 555–564. 54 indexed citations
17.
Sun, Wei, Xiabin Lan, Hao Zhang, et al.. (2018). NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer. Cell Death and Disease. 9(3). 380–380. 72 indexed citations
18.
Liu, Jinhao, Wei Sun, Wenwu Dong, et al.. (2017). HSP90 inhibitor NVP-AUY922 induces cell apoptosis by disruption of the survivin in papillary thyroid carcinoma cells. Biochemical and Biophysical Research Communications. 487(2). 313–319. 19 indexed citations
19.
Sun, Wei, Xiabin Lan, Zhihong Wang, et al.. (2016). Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer. Medical Oncology. 33(9). 102–102. 24 indexed citations
20.
Huang, Yanhong, Wenwu Dong, Jing Li, et al.. (2014). Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma. BMC Cancer. 14(1). 383–383. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minghua Ge Breakdown of academic impact, for papers by Youben Fan Breakdown of academic impact, for papers by Trisha Dwight Breakdown of academic impact, for papers by Qinghai Ji Breakdown of academic impact, for papers by Ning Qu Breakdown of academic impact, for papers by Weiming Lv Breakdown of academic impact, for papers by Tian Liao Breakdown of academic impact, for papers by Shigeto Maeda Breakdown of academic impact, for papers by Euy Young Soh Breakdown of academic impact, for papers by Agnese Biagini
Rankless by CCL
2026